Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2018
Price : $35 *
At a glance
- Drugs Avatrombopag (Primary)
- Indications Thrombocytopenia
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 15 Jun 2018 Results of pooled data from 14 trials, were published in the Journal of Clinical Pharmacology.
- 17 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.